Jump to search

March 2021

First stem cell clinical trial for spina bifida treatment announced

March 1, 2021

A UC Davis Health team today announced the launch of the world’s first FDA-approved human clinical trial to treat the most serious form of spina bifida. The trial involves the use of stem cells, applied during a surgery before birth.

February 2021

New mini-medical school seeks to engage, serve Sacramento’s Vietnamese community

February 26, 2021

Vietnamese mini-medical school, an educational outreach effort by CTSC program and the Alzheimer’s Disease Research Center, is open for registration.

UC Davis School of Medicine scored a record year of NIH funding

February 23, 2021

In 2020, the UC Davis School of Medicine secured its highest-ever level of National Institutes of Health research funding at more than $181 million.

UC Davis Health joins Mount Sinai, Cleveland Clinic and Northwestern in grant to implement and evaluate IBD Digital Therapeutics Toolkit within EHR

February 19, 2021

UC Davis Health has joined with several of the nation’s top health systems to help launch a NIH-sponsored initiative for an new digital therapeutics toolkit targeting inflammatory bowel disease.

January 2021

Twelve COVID-19 treatments being tested at UC Davis School of Medicine

January 28, 2021

In the search for potential COVID-19 treatments, UC Davis School of Medicine is recruiting participants for more than 12 clinical trials.

UC Davis receives $3.2 million grant to study age-related macular degeneration

January 19, 2021

Glenn Yiu, an associate professor in the Department of Ophthalmology and Vision Science, has been awarded a five-year, $3.2 million grant from the National Institutes of Health National Eye Institute for a study on age-related macular degeneration, or AMD.

Fewer behavior problems in young foster care kids after PC-CARE program

January 14, 2021

A new study finds that young children in the foster care system demonstrated fewer behavior problems after participating in an innovative seven-week intervention. The program is called PC-CARE, and was pioneered at UC Davis CAARE Center.

Exposure to violence takes a toll on the socioemotional well-being of Californians

January 14, 2021

A survey of Californians finds that exposure to violence has pervasive social and emotional impacts on people, especially when firearms are involved.

Research on COVID-19 vaccine includes data from UC Davis School of Medicine

January 13, 2021

The New England Journal of Medicine published a peer-reviewed paper on the newly available Pfizer COVID-19 vaccine. It includes clinical trial data collected from UC Davis Health, the only academic medical center on the West Coast to take part in the study.

Innovative serotonin sensor to improve neurological drug development

January 11, 2021

UC Davis researchers developed and used an innovative sensor to track serotonin in the brains of mice during social interactions, fearful situations and sleep/wake conditions. Sensor can help in developing better neuropsychological drugs for depression and other conditions.

Concerns about violence increase in California amid COVID-19 pandemic

January 4, 2021

Study finds that people in California are more worried about violence during COVID-19 pandemic.